Literature DB >> 20429808

Time-dependent reduction in the anticonvulsant effectiveness of diazepam against soman-induced seizures in guinea pigs.

John H McDonough1, Joseph D McMonagle, Tsung-Ming Shih.   

Abstract

Near-lethal exposure to nerve agents produces prolonged epileptiform seizures requiring the administration of benzodiazepine anticonvulsant drugs, such as diazepam. Clinically, benzodiazepines are reported to lose anticonvulsant effectiveness the greater the delay between seizure onset and benzodiazepine treatment. This time-dependent diminished effectiveness of diazepam was tested in the present study. Seizures elicited by the nerve agent, soman, were produced in guinea pigs instrumented to record brain electrocorticographic (ECoG) activity. Different groups of animals were administered 10 mg/kg, intramuscularly, of diazepam at 5, 40, 60, 80, or 160 minutes after the onset of seizure activity. There was a progressive loss in the anticonvulsant efficacy of diazepam as the treatment was delayed after seizure onset, but no differences in the time for diazepam to stop seizures. The results show a diminished ability of diazepam to stop nerve-agent-induced seizures the longer treatment is delayed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20429808     DOI: 10.3109/01480540903483417

Source DB:  PubMed          Journal:  Drug Chem Toxicol        ISSN: 0148-0545            Impact factor:   3.356


  29 in total

1.  Susceptibility to Soman Toxicity and Efficacy of LY293558 Against Soman-Induced Seizures and Neuropathology in 10-Month-Old Male Rats.

Authors:  James P Apland; Vassiliki Aroniadou-Anderjaska; Taiza H Figueiredo; Eric M Prager; Cara H Olsen; Maria F M Braga
Journal:  Neurotox Res       Date:  2017-08-03       Impact factor: 3.911

2.  The limitations of diazepam as a treatment for nerve agent-induced seizures and neuropathology in rats: comparison with UBP302.

Authors:  James P Apland; Vassiliki Aroniadou-Anderjaska; Taiza H Figueiredo; Franco Rossetti; Steven L Miller; Maria F M Braga
Journal:  J Pharmacol Exp Ther       Date:  2014-08-25       Impact factor: 4.030

Review 3.  Midazolam as an anticonvulsant antidote for organophosphate intoxication--A pharmacotherapeutic appraisal.

Authors:  Sandesh D Reddy; Doodipala Samba Reddy
Journal:  Epilepsia       Date:  2015-05-29       Impact factor: 5.864

4.  Midazolam-Resistant Seizures and Brain Injury after Acute Intoxication of Diisopropylfluorophosphate, an Organophosphate Pesticide and Surrogate for Nerve Agents.

Authors:  Xin Wu; Ramkumar Kuruba; Doodipala Samba Reddy
Journal:  J Pharmacol Exp Ther       Date:  2018-08-16       Impact factor: 4.030

5.  Neuroprotective efficacy of caramiphen against soman and mechanisms of its action.

Authors:  T H Figueiredo; V Aroniadou-Anderjaska; F Qashu; J P Apland; V Pidoplichko; D Stevens; T M Ferrara; M F M Braga
Journal:  Br J Pharmacol       Date:  2011-11       Impact factor: 8.739

6.  Delayed midazolam dose effects against soman in male and female plasma carboxylesterase knockout mice.

Authors:  Erica Kundrick; Brenda Marrero-Rosado; Michael Stone; Caroline Schultz; Katie Walker; Robyn B Lee-Stubbs; Marcio de Araujo Furtado; Lucille A Lumley
Journal:  Ann N Y Acad Sci       Date:  2020-02-06       Impact factor: 5.691

7.  Effect of acute soman exposure on GABA(A) receptors in rat hippocampal slices and cultured hippocampal neurons.

Authors:  Yushan Wang; Lidong Liu; Tracy Weiss; Christine Stewart; John Mikler
Journal:  Neurotox Res       Date:  2011-06-04       Impact factor: 3.911

Review 8.  Neurosteroids for the potential protection of humans against organophosphate toxicity.

Authors:  Doodipala Samba Reddy
Journal:  Ann N Y Acad Sci       Date:  2016-07-23       Impact factor: 5.691

9.  Oral Pretreatment with Galantamine Effectively Mitigates the Acute Toxicity of a Supralethal Dose of Soman in Cynomolgus Monkeys Posttreated with Conventional Antidotes.

Authors:  Malcolm Lane; D'Arice Carter; Joseph D Pescrille; Yasco Aracava; William P Fawcett; G William Basinger; Edna F R Pereira; Edson X Albuquerque
Journal:  J Pharmacol Exp Ther       Date:  2020-08-05       Impact factor: 4.030

10.  Midazolam-ketamine dual therapy stops cholinergic status epilepticus and reduces Morris water maze deficits.

Authors:  Jerome Niquet; Roger Baldwin; Keith Norman; Lucie Suchomelova; Lucille Lumley; Claude G Wasterlain
Journal:  Epilepsia       Date:  2016-08-08       Impact factor: 5.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.